Literatur
-
1 Böhm M, Erdmann E. Therapie
der chronischen Herzinsuffizienz. Springer Verlag Heidelberg In:
Klinische Kardiologie, Erdmann E (Hrsg.) 2000: 612-700
-
2
Braunwald E.
Effects
of digitalis on the normal and the failing heart.
J Am
Coll Cardiol.
1985;
5
51A-59A
-
3
Christian H A.
Digitalis
effects in chronic cardiac cases with regular rhythm in contrast
to auricular fibrillation.
Med Clin North Am.
1922;
5
1173-1190
-
4
Cohn J N, Levine T B, Olivari M T, Gerberg V, Lura D, Francis G S, Simon A B, Rector T.
Plasma
norepinephrine as a guide to prognosis in patients with chronic
congestive heart failure.
N Engl J Med.
1984;
311
819-823
-
5
DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant R C, Wright R. for the Milrinone Multicenter
Trial Group .
Oral milrinone and digoxin in heart failure:
results of a placebo controlled prospective trial of each agent
and the combination.
N Engl J Med.
1989;
320
677-683
-
6
Feldman M D, Alderman J D, Aroesty J M, Royal H D, Ferguson J J, Owen R M, Grossman W, McKay R G.
Depression
of systolic and diastolic myocardial reserve during atrial pacing
tachycardia in patients with dilated cardiomyopathy.
J
Clin Invest.
1988;
82
1661-1669
-
7
Fleg J L, Gottlieb S H, Lakatta E G.
Is digoxin really important in treatment
of compensated heart failure? A placebo-controlled crossover study
in patients with sinus rhythm.
Am J Med.
1982;
73
244-250
-
8
Fleg J L, Rothfeld B, Gottlieb S H.
Effect
of maintenance digoxin therapy on aerobic perfomance and exercise
left ventricular function in mild to moderate heart failure due
to coronary artery disease: A randomized, placebo-controlled, cross-over
trial.
J Am Coll Cardiol.
1991;
17
743-751
-
9
Ferguson D W, Berg W J, Sanders J S.
Clinical and hemodynamic correlates of sympathetic
nerve activity in normal humans and patients with heart failure.
Evidence from direct microneurographic recordings.
J Am
Coll Cardiol.
1990;
82
1724-1729
-
10
Ferguson D W, Berg W J, Sanders J S. et al .
Sympathoinhibitory responses
to digitalis glycosides in heart failure patients. Direct evidence
from sympathetic neural recordings.
Circulation.
1989;
80
65-70
-
11
Gheorghiade M, Hall V, Lakier B J, Goldstein S.
Comparative hemodynamic
and neurohormonal effects of intravenous captopril and digoxin and
their combinations in patients with severe heart failure.
J
Am Coll Cardiol.
1989;
13
134-142
-
12
Gheorghiade M, St Clair J, St Clair C, Beller G.
Hemodynamic effects of intravenous
digoxin in patients with severe heart failure initially treated
with diuretics and vasodilators.
J Am Coll Cardiol.
1989;
9
949-957
-
13
German and Austrian Xamoterol
Study Group .
Double-blind placebo-controlled comparison
of digoxin and xamoterol in chronic heart failure.
Lancet.
1988;
I
488-492
-
14
Guyatt G H, Sullivan M JJ, Fallen E L. et al .
A controlled trial of digoxin
in congestive heart failure.
Am J Cardiol.
1988;
61
371-375
-
15
Higgins C B, Vatner S F, Eckberg D L, Braunwald E G.
Alterations
in the baroreceptor reflex in conscious dogs with heart failure.
J
Clin Invest.
1972;
51
715-224
-
16
Hirsch A T, Dzau V J, Creager M A.
Baroreceptor function in congestive heart
failure: Effect on neurohumoral activation and regional vascular
resistance.
Circulation.
1987;
75
IV36-IV48
-
17
Iesaka Y, Aonuma K, Gosselin A J. et al .
Susceptibility of infracted canine hearts
of digitalis-toxic ventricular tachycardia.
J Am Coll
Cardiol.
1983;
2
45-51
-
18
Lee D C-S, Johnson R A, Bingham J B. et al .
Heart failure in outpatients:
a randomized trial of digoxin versus placebo.
N Engl J
Med.
1982;
306
699-705
-
19
Lindsay S J, Keamey M T, Prescott R J, Fox K AA, Nolan J. for the UK Heart Investigation .
Digoxin
and mortality in chronic heart failure.
The Lancet.
1999;
354
1003
-
20
Luten D.
Clinical
studies of digitalis: Effects produced by administration of massive
dosage to patients with normal mechanism.
Arch Inter Med.
1924;
33
251-278
-
21
McClements B M, Adgey A AJ.
Value of signal-averaged
electrocardiolography, radionuclide ventriculopathy, Holter monitoring
and clinical variables for prediction of arrhythmic events in survivors
of acute myocardial infarction in the thrombolytic era.
J
Am Coll Cardiol.
1993;
21
1419-1427
-
22
Nolan J, Batin P D, Andrews R. et al .
Prospective study of heart rate variability
and mortality in chronic heart failure; results of the United Kingdom
Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART).
Circulation.
1998;
98
1510-1516
-
23
Packer M, Carver J R, Rodeheffer R J. et al .
Effect of oral milrinone
on mortality in severe chronic heart failure.
N Engl J
Med.
1991;
325
1468-1475
-
24
Packer M, Gheorghiade M, Young J B. et al. for the RADIANCE-Study .
Withdrawal of digoxin
from patients with chronic heart failure treated with angiotensin-converting
enzyme inhibitors.
N Engl J Med.
1993;
329
1-7
-
25
Ribner H S, Plucinski D A, Hsieh A. et al .
Acute effects of digoxin on total systemic
vascular resistance in congestive heart failure due to dilated cardiomyopathy:
A hemodynamic-hormonal study.
Am J Cardiol.
1985;
56
896-904
-
26
Schobel H P, Oren R M, Roach P J. et al .
Contrasting effects of digitalis and
dobutamine on baroreflex sympathetic control in normal humans.
Circulation.
1991;
84
1118-1129
-
27
Schwinger R HG, Böhm M, Koch A, Schmidt U, Morano I, Eissner H J, Überfuhr P, Reichart B, Erdmann E.
The failing human heart is unable to use
the Frank-Starling mechanism.
Circ Res.
1994;
74
959-969
-
28
Schwinger R HG, Böhm M, M& uuml;ller-Ehmsen J, Uhlmann R, Schmidt I J, Stäblein A, Überfuhr P, Kreuzer E, Reichart B, Eissner H J, Erdmann E.
Effect of inotropic
stimulation on the negative force-frequency-relationship in the
failing human heart.
Circulation.
1993;
88
2267-2276
-
29
Spargias S K, Hall S A, Ball G S.
Safety concerns about digoxin after acute
myocardial infarction.
The Lancet.
1999;
354
391-392
-
30
Taggart A J, Johnston G D, McDevitt D G.
Digoxin withdrawal after cardiac failure
in patients with sinus rhythm.
J Cardiovasc Phamacol.
1983;
5
229-234
-
31
Thames M D, Waickman L A, Abboud F M.
Sensitization of cardiac receptors (vagal
afferents) by intracoronary acetylstrophanthidin.
Am J Phyiol.
1980;
239
H628-H635
-
32
The AIRE study investigators .
Effect
of ramipril on mortality and morbidity of survivors of acute myocardial
infarction with clinical evidence of heart failure.
Lancet.
1993;
343
821-828
-
33
The Captopril-Digoxin Multicenter
Research Group .
Comparative effects of Captopril and
digoxin in patients with mild to moderate heart failure.
JAMA.
1988;
259
539-555
-
34
The Consensus Trial Study
Group .
Effects of enalapril on mortality in severe
congestive heart failure: results of the Cooperative North Scandinavian
Enalapril Survival Study (CONSENSUS).
N Engl J Med.
1987;
316
1429-1435
-
35
The Digitalis Investigation
Group (DIG) .
The effect of digoxin on mortality and
morbidity in patients with heart failure.
N Engl J Med.
1997;
336
525-533
-
36
Uretsky B F, Young J B, Shadidi F E. et al. on behalf of the PROVED Investigative
Group .
Randomized study assessing the effect of digoxin withdrawal
in patients with mild to moderate chronic congestive heart failure:
Results of the PROVED trial.
J Am Coll Cardiol.
1993;
22
955-964
-
37
Varonkow Y, Shell W E, Smirnov V, Gukovsky D, Chazov E I.
Augmentation
of serum CPK activity by digitalis in patients with acute myocardial
infarction.
Circulation.
1977;
55
719-727
-
38 Withering W. An
account of the foxglove and some if its medical uses, with practical
remarks on dropsy and other diseases. New York, NY, Schuman In
Willins FAa, Keyes TE (ed): Classics of Cardiology 1941: 231-252
-
39
Zucker I H, Peterson T V, Gilmore J P.
Ouabain increases left atrial stretch receptor
discharge in the dog.
J Pharmacol Exp Therap.
1980;
212
320-324
Prof. Dr. med. M. Böhm
Direktor der Med. Univ.-Klinik und Poliklinik, Innere
Medizin III
Kirrberger Straße
66421
Homburg/Saar
Phone: 06841/1623372
Fax: 06841/1623369
Email: boehm@med-in.uni.uni-saarland.de
